Alzheimer’s Disease among American Minority Populations: An Ecological Exploratory Study by Laquaglia, Maria et al.
12
Journal of Geriatric Medicine | Volume 03 | Issue 01 | April 2021
Distributed under creative commons license 4.0 DOI: https://doi.org/10.30564/jgm.v3i1.2907
Journal of Geriatric Medicine
https://ojs.bilpublishing.com/index.php/jgm
ARTICLE
Alzheimer’s Disease among American Minority Populations: An Eco-
logical Exploratory Study 
Maria LaQuaglia*　Marina Celly Martins Ribeiro de Souza*　Carolina Marques Borges 
Department of Public Health, School of Nursing, Health and Exercise Science, The College of New Jersey, USA. 
ARTICLE INFO ABSTRACT
Article history
Received: 22 February 2021
Accepted: 22 March 2021 
Published Online: 15 April 2021 
A significant public health concern with regards to increasing rates of 
Alzheimer’s is that it disproportionately affects minority groups in the 
United States. The present ecological exploratory study uses secondary 
aggregate data from the fifty United States in the year of 2019. The pur-
pose of this study was to address the disparities in Alzheimer’s in minori-
ty populations in the US and explore associated factors. The “minority” 
populations considered were African American and Hispanic populations, 
and the “majority” population was referred to as “white”. The data were 
extracted from the United States Census Bureau, the CDC National Cen-
ter for Health Statistics, and the Behavioral Risk Factor Surveillance Sys-
tem (BRFSS) Dataset. The prevalence rates of Alzheimer’s disease are 
greatest in both older Hispanic (12.2%) and African Americans (13.8%), 
compared to older whites (10.3%) in the investigated time period.  Our 
results showed that being over 65 years old (p=.009), with a below-av-
erage ($62,843) median household income (p=.024), history of stroke 
(p=.029), and being a part of the Hispanic population (p=.036), were 
significantly associated with Alzheimer’s mortality rates in the United 
States. By identifying disparities in access to Alzheimer’s healthcare and 
at-risk communities, more comprehensive intervention strategies can be 
developed to promote change and advocate for more Alzheimer’s educa-
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1. Introduction
Alzheimer’s disease is defined as a brain disorder 
that progressively gets worse over time [1]. According 
to the National Institute on Aging, Alzheimer’s is “ir-
reversible” and slowly inhibits an individual’s ability 
to carry out basic bodily tasks that are necessary for 
survival [1]. Generally, individuals will begin to dis-
play symptoms of Alzheimer’s around the age of 65 
[1]. Though quite rare, those who display symptoms 
between the ages of thirty to early sixties, are classified 
as “early-onset” [1]. According to Healthy People 2020, 
“Alzheimer’s disease is the most common form of de-
mentia” [2]. In general, “Dementia” inhibits an individ-
ual’s ability to function independently, maintain good 
health, and optimal well-being; symptoms typically 
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include memory loss and problems understanding lan-
guage and communicating [2]. 
Alzheimer’s develops from a variety of factors that 
include genetics, lifestyle choices, environment, with 
the greatest risk factor being over the age of 65 [3]. 
Though some factors are impossible to prevent, it is 
important for individuals to protect the brain from sub-
stantial head injury, maintain a healthy heart, healthy 
diet, exercise, socialization, and avoid alcohol or tobac-
co in order to age in the healthiest way [3]. Brain health 
is strongly associated with heart health; so, conditions 
like heart disease, diabetes, and stroke are associated 
with higher risk of developing Alzheimer’s [3]. Alzhei-
mer’s does not only affect the individual receiving the 
diagnosis but impacts the family members and care-
givers that the individual must rely on [4]. To explain, 
the total cost of care for Americans with Alzheimer’s 
in 2017 has been estimated to be 232 billion dollars 
and about 18.4 billion hours of care [4]. Such extensive 
amounts of time and money that come with caring for 
an individual with Alzheimer’s underscore the impor-
tance of knowing the associated factors in order to 
receive the earliest diagnosis so that symptoms do not 
become more severe. 
The prevalence of Alzheimer’s is increasing globally 
but varies by country due to cultural and socioeconom-
ic differences [5]. Generally, prevalence is greater in 
more developed countries and lower in underdeveloped 
countries [5]. It is most prevalent in the Americas and 
is least prevalent in less developed countries, such as 
Africa and the Middle East [5]. The proportion of indi-
viduals from developed countries with Alzheimer’s is 
expected to be 71.2% by 2040; an increase from 60.1% 
in 2001 [5]. The disparity in prevalence of Alzheimer’s 
in developed countries versus underdeveloped coun-
tries can be supported by differences in average life 
expectancy. Typically, individuals living in developed 
countries will have a longer lifespan as compared to 
individuals in underdeveloped countries [6]. Older age is 
highly associated with developing Alzheimer’s [6]. It is 
predicted that the number of individuals over 65 living 
in developed countries is expected to hit 1 billion by 
2030, which will affect future incidence rates of Alz-
heimer’s [6].
Currently, 5.8 million Americans aged 65 and older 
are living with Alzheimer’s disease (1 in ten Amer-
icans) [7]. It is the sixth leading cause of death in the 
United States overall, and the fifth-leading cause of 
death in individuals over 65 years old [7]. Individuals 
with Alzheimer’s experience a high level of morbidity 
caused by years of poor health and disability, which 
gradually becomes more severe. Mortality generally 
results from complications related to years of living 
with poor health [6]. Reported deaths from Alzheimer’s 
has increased 146.2% from 2000 to 2018 in the US 
[8]. According to the CDC, age-adjusted death rates by 
state range from 13.9 to 46.5 in New York and Georgia, 
respectively [9]. Death rates are generally the lowest 
for states in the North-East, and the highest for states 
in the South-East United States [9]. Trends indicate that 
incidence/prevalence of Alzheimer’s will continue to 
increase as people continue to live longer and longer [1]. 
According to the Alzheimer’s Association, “older 
Hispanics are about one-and-a-half times as likely as 
older whites to have Alzheimer’s and other dementias, 
while older African-Americans are about twice as like-
ly to have the disease as older whites” [3]. This disparity 
served as the basis for this present study. Currently, 
there is a gap in Alzheimer’s research amongst minori-
ty populations in the United States as compared to the 
majority population [8]. The “minority” populations for 
this study refer to African Americans and Hispanic pop-
ulations, while the “majority” refers to mostly whites. 
The purpose of this study is to address the disparities in 
Alzheimer’s in minority populations and explore influ-
encing factors. 
The overall research goal is to analyze the recent 
trends of Alzheimer’s mortality in the United States 
in minority populations compared to the majority and 
address possible explanations. Our hypotheses are first, 
Hispanic & African American populations had the high-
est prevalence of Alzheimer’s in 2019. Second, Ethnic 
groups in the US that fall within the minority will show 
higher rates of Alzheimer’s onset. The null hypothesis 
is the distribution of Alzheimer’s mortality in the in-
vestigated period is not associated with being a part of 
a minority population in the United States. 
2. Methods
The goal of our study was to test a potential associ-
ation between Alzheimer’s mortality rates with being a 
part of a minority population in the United States. We 
designed an analytical ecological exploratory study us-
ing secondary aggregate data. Each individual state in 
the United States represented a single unit of analysis. 
The major outcome of our study was mortality due 
to Alzheimer’s disease, which served as our dependent 
variable. To reiterate, Alzheimer’s is defined as a brain 
disease that progressively worsens over time and even-
tually makes it impossible for individuals to carry out 
basic bodily functions [1]. Mortality due to Alzheimer’s 
is increasing in the United States, as death results from 
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years of living with health complications that progres-
sively worsen [8]. Our research specifically focused on 
disparities in mortality rates among minority popula-
tions versus majority. This is because we wanted to 
recognize the gaps that currently exist in Alzheimer’s 
research in minority populations. In sum, we explored 
an association between being a part of a minority pop-
ulation in the United States with Alzheimer’s mortality, 
along with several other explanatory variables. 
The dependent variable was Alzheimer’s mortality 
rates [number of people that died due to Alzheimer’s 
disease in the year of 2019 divided by the total popu-
lation of the same year]. The independent variables in 
our study consist of each state's general population, and 
the percentage of each state’s population of individuals 
over 65 years old. The main exposure we are investi-
gating is being a part of a minority race population. So, 
we included the percentages of people that belong to 
“White alone”, “African-American”, and “Hispanic” 
populations. Other variables included; percentage of 
the population that has a bachelor’s degree or higher, 
percentages of the population without health insurance, 
median household income [total income divided by the 
number of people living the household], adult obesity 
rates [people with BMI => 30 divided by total popula-
tion size], prevalence of stroke [number of Americans 
who have had a stroke divided by total U.S. popula-
tion], and prevalence of diabetes [number of Americans 
diagnosed with type II diabetes divided by total U.S. 
population].
The secondary data used in this study were extracted 
from the United States Census Bureau, the CDC Na-
tional Center for Health Statistics, and the Behavioral 
Risk Factor Surveillance System (BRFSS) Dataset. 
We chose these sources of data because they are re-
liable, widely recognized open-access databases that 
include expansive information on each of the 50 states. 
We completed statistical testing using SPSS statistical 
software. The statistical tests we applied were bivariate 
analysis, followed by multivariate analysis and linear 
regression. 
First, we tested our main outcome and every single 
variable first to determine if there was any association 
with our dependent variable, Alzheimer’s mortality. All 
variables that had a level of significance equal to or be-
low 0.2 were included in the regression analysis. Next, 
we took the associated independent variables and per-
formed a linear regression using the “Enter” method. 
As a result, we were able to determine which variables 
remained associated with our dependent variable when 
influenced by our other independent variables. 
3. Results 
The main objective of our study was to explore any 
possible association with Alzheimer’s mortality and 
being a part of a minority race in the United States. So, 
we considered data belonging to the African American 
population and the Hispanic population as representing 
“minorities”, while White alone represents the “major-
ity”. We also tested for possible association with other 
independent variables on Alzheimer’s mortality as well. 
The results of our statistical testing are explained in the 
following paragraphs. 
3.1 Descriptive Analysis
Descriptive analysis shows that of the total United 
States (N = 50), the mean of the population aged over 
65 years old is roughly 17%, 8% are uninsured, and 
32% have achieved a bachelor’s degree or higher. In 
terms of race distribution in the United States popula-
tion, 79% are White alone, 11% are African American, 
12% are Hispanic. These percentages are rounded up 
or down by 1% by looking at the closest decimal point. 
Descriptive analysis also showed high rates of other 
comorbidities, obesity, stroke, and diabetes. The mean 
rates of obesity, stroke and diabetes in the United States 
are 32%, 37%, and 22%, respectively (Table 1). 
Table 1. Descriptive statistics according to investigated 
variables. USA, 2019.
Variables Minimum Maximum Mean Std. Deviation
Total Popula-
tion 578,759.00 39512223.00 6550855.4800 7389409.68284
People aged 








.60 37.80 11.1900 9.62656
Race/Ethnic-
ity Hispanic 1.70 49.30 12.2660 10.45349
Median 
Income 43567.00 81868.00 60172.0000 9920.06437
Obesity 
Prevalence 23.80 40.80 32.1020 3.86763
History of 
Stroke 24.40 51.80 36.8080 6.10807





20.30 79.30 31.6502 8.58020
Diabetes 
Prevalence 14.60 36.20 21.9500 4.39147
DOI: https://doi.org/10.30564/jgm.v3i1.2907
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Table 2. Bivariate analysis among Alzheimer’s mortality 
rates and investigated independent variables.
Variables Significance Level
Total Population .846
People aged 65+ .053
Race/Ethnicity White alone .713




History of Stroke .000
Uninsured .008
EducationBachelor’s Degree or Higher .181
Diabetes Prevalence .002
Median income (.001), obesity (.002), history stroke 
(.000), being uninsured (.008), prevalence of diabetes 
(.002), being over 65 years old (.053), education level 
(.181), being African American (.114), and being His-
panic (.086) were inserted in the linear regression Model 
(Table 3). After controlling by the above-mentioned vari-
ables, being over 65 years old (p=0.009), median income 
(p=0.024), history of stroke (p=0.029), and being Hispan-
ic (p=0.036) were strongly associated with Alzheimer’s 
mortality in the United States. 
Table 3. Final model regression analysis.
Variables B* Std. Error* Beta** t Sig. 
(Constant) 77.032 29.097 2.647 .012
People aged 








-.252 .116 -.308 -2.174 .036
Median 
Income .000 .000 -.480 -2.355 .024
Obesity 
Prevalence -.550 .471 -.248 -1.169 .249
History of 
Stroke .595 .262 .424 2.269 .029





.119 .143 .119 .829 .412
Diabetes 
Prevalence .229 .384 .117 .596 .554
Dependent Variable: Alzheimer’s Mortality; * Unstandardized Coeffi-
cients; ** Standardized Coefficients
4. Discussion
Associations between being a part of a minority group 
with an increased incidence of certain diseases in the 
United States have been discussed in existing literature. 
According to the National Institute of Allergy and Infec-
tious Diseases, it has been widely “recognized that racial 
and ethnic differences affect susceptibility to infection and 
disease” [9]. Examples of these disparities include African 
Americans “represent almost half of new AIDS diagno-
ses”, asthma disproportionately affects African American 
and Hispanic children in the inner-city, African Americans 
account for some of the “highest rates of chronic Hepatitis 
C and Hepatitis C-related deaths”, and systemic lupus ery-
thematosus can be up to three times more common among 
African American and Hispanic women [9]. 
It is also important to recognize other significant Alz-
heimer’s disease patterns throughout the United States. 
Existing data from the CDC show that age-adjusted death 
rates due to Alzheimer’s are highest in the southeastern 
region of the U.S., with the exception of Florida [10]. States 
with death rates ranging from 44.9 – 46.5 include: Ala-
bama, Tennessee, Washington, Mississippi, and Georgia, 
respectively [10]. On the other hand, states with the lowest 
death rates due to Alzheimer’s are generally located in the 
northeastern region of the United States [10]. States with 
death rates ranging from 13.9 – 19.5 include: New York, 
Maryland, Connecticut and Massachusetts [10]. Florida 
and Hawaii also have some of the lowest death rates due 
to Alzheimer’s nationally, but are not a part of the north-
eastern region [10]. Recognizing differences in the disease 
patterns of Alzheimer’s in the U.S. is important for deter-
mining if states with higher death rates also have higher 
populations of minority groups.
The Centers for Disease Control and Prevention (CDC) 
have concluded that Hispanic and African American 
populations will experience the largest increase in Alz-
heimer’s disease and related dementias [7]. In the United 
States minority populations will be affected the most by 
Alzheimer’s disease by the year 2060, when it is predict-
ed that cases will rise to about 1 million people [7]. Our 
results showed significant associations among being His-
panic (p=.036), being over 65 years old (p=.009), median 
income (p=.024), and history of stroke (p=.029) with on-
set of Alzheimer's in the United States. According to the 
CDC, within the next 40 years Alzheimer’s cases among 
Hispanic populations will increase seven times over to-
day’s estimates, and four times over today’s estimates 
among African Americans [7]. This underscores why the 
main objective of our study was to investigate the associ-
ation between being a part of either the Hispanic popula-
DOI: https://doi.org/10.30564/jgm.v3i1.2907
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tion or African American population in the United States 
with Alzheimer’s disease. The significant association we 
found with being Hispanic and Alzheimer’s disease in the 
United States corroborates with existing literature from 
the Alzheimer’s Association [7].
The significant association we found between being 
over 65 years old and the onset of Alzheimer’s has also 
been discussed in existing literature [1]. The National In-
stitute of Aging points out that age-related changes in the 
brain may harm neurons and affect other types of brain 
cells to contribute to Alzheimer’s damage [8]. It is impera-
tive to recognize that the general population of the United 
States is not only aging, but also living longer. This aging 
population impacts not only the morbidity rates of Alz-
heimer’s in the United States, but also contributes to large 
increases in the costs of Alzheimer’s treatment. 
We understand that it was important to take into ac-
count other social determinants of health that minorities 
in the United States face that may account for increased 
risk for developing Alzheimer’s. Instead of considering 
only two specific ethnic populations, we also analyzed so-
cial determinants of health that may affect these minority 
populations. The National Institute on Aging informs that 
a variety of health, environmental, and lifestyle factors 
beyond genetics and natural aging can play a role in the 
onset of Alzheimer’s [8]. This served as the basis for what 
other explanatory factors we chose as independent vari-
ables in our study. 
Disparities in education, income, and access to health 
care/insurance that minorities experience can impact Alz-
heimer's onset [7]. For example, we found that income is 
a significant predictor of developing Alzheimer's. This 
association relates to how minority populations tend to 
have lower median income levels compared to majority 
populations in the U.S. low socioeconomic status among 
minority populations exacerbates the social determinants 
of health that may contribute to Alzheimer’s onset. To 
explain, lower household income is associated with a lack 
of health insurance coverage, access to health screenings, 
adequate health education and consistent healthcare. All 
of which increase the risk for developing Alzheimer’s 
disease. Moreover, the relationship between income level 
and being a part of a minority in the U.S. can largely ac-
count for the increased prevalence of Alzheimer’s rates in 
minority populations. 
Additional research suggests that vascular conditions 
such as stroke, diabetes, and obesity contribute to de-
veloping Alzheimer’s [8]. Our results show that stroke is 
associated with the onset of Alzheimer’s. According to the 
National Heart, Lung, and Blood Institute there are a vari-
ety of risk factors that increase the probability of having a 
stroke [9]. These factors include an unhealthy diet, lack of 
exercise, and an excessive use of alcohol and/or tobacco 
[9]. We understand that it is not justifiable to generalize 
the overall health habits of an entire ethnic population. 
However, we do acknowledge that minority populations 
are typically but not always, more susceptible to the en-
vironmental/lifestyle factors and social determinants of 
health that can increase risk for stroke. The association we 
found between stroke and Alzheimer’s could account for 
disparities in rates of Alzheimer’s in American minority 
populations. 
It is also imperative to address the current chronic 
disease epidemic. Incidence of obesity, Type 2 diabetes, 
non-alcoholic fatty liver disease (NAFLD) and neurode-
generative diseases are increasing globally [11]. Obesity 
and type 2 diabetes prevalence is predicted to rise to 30% 
of the global population, and prevalence of NAFLD in 
Western countries is currently at 30% [11]. Unhealthy di-
ets and sedentary lifestyles are the major contributors to 
developing the aforementioned chronic diseases [11]. To 
reiterate, we understand that it is not justifiable to make 
generalizations, but we do recognize that minority pop-
ulations may be more highly susceptible to the lifestyle 
factors that may contribute to such chronic diseases that 
ultimately impact Alzheimer’s development. For example, 
the Hispanic population in the United States has the high-
est rates of diabetes in adults and children, compared to 
any other race group [12]. Prevalence and incidence of type 
2 diabetes is higher than the national average, despite His-
panics being the largest minority population in the United 
States [12]. Because additional research suggests that diabe-
tes and obesity contribute to developing Alzheimer’s, we 
cannot ignore that Hispanics are affected by the diabetes 
epidemic and are therefore at higher risk for developing 
Alzheimer’s [8].
Nutritional and environmental factors impact the re-
pression of certain anti-aging genes. To explain the an-
ti-aging gene Sirtuin 1 is calorie sensitive, and therefore 
inactivated by unhealthy diets [13]. Research suggests that 
Sirtuin 1 (Sirt 1) is linked to the chronic disease epidemic 
discussed in the paragraph above [13]. There is an associ-
ation between Sirt 1 being repressed early in the aging 
process due to chronic and neurogenerative diseases (in-
cluding Alzheimer’s disease) and programmed cell death 
[14]. According to the Journal of Diabetes & Metabolic 
Disorders, “Unhealthy western diets and lifestyles lead 
to circadian rhythm disorders with defective nutrient and 
caffeine metabolism associated with NAFLD, cardiovas-
cular disease and T3D diabetes in the developed world” 
[15]. Implementing nutritional interventions in the United 
States would be an effective way to confront the chronic 
DOI: https://doi.org/10.30564/jgm.v3i1.2907
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disease epidemic because overeating is directly associated 
with increased risk for the chronic diseases that are asso-
ciated with a defective Sirt 1 gene [15]. Moreover, Sirtuin 
1 is an anti-aging gene proven to become defective in 
the presence of unhealthy diets and is exacerbated by the 
chronic disease epidemic disproportionally affecting mi-
nority populations in the United States [13]. 
5. Study Limitations & Strengths
The first limitation of this study that should be consid-
ered is the ecological fallacy. The present study used sec-
ondary data to gather information from all of the 50 Unit-
ed States. We used secondary data from the Census.gov 
for each state’s general population, including the percent-
age of that entire state population that is either Hispanic or 
African American. By considering the entire United States 
population, we recognize that there is a limitation with 
how many individuals actually contribute personal data to 
the Census. Thereby possibly skewing the accuracy of our 
generalized population data due to those who chose not to 
participate. 
A second limitation relates to our method. We decided 
to focus on Hispanic and African American populations 
because they are the two largest minority populations in 
the United States, considering Census data. But we recog-
nize that there are various other minority populations in 
the United States that we did not consider, and that vari-
ous other minorities should be considered in future studies 
and research on the same topic. It should be noted that our 
analysis did not confirm that African Americans were as-
sociated with and faced equal disparities to Hispanic pop-
ulations, however other studies pointed out the contrary. 
This can be due to reverse causation and or due to the fact 
that this data could be under reported.
Other limitations include not being able to follow up 
on participants of a study to understand if their health 
conditions have improved and how it impacts their current 
overall health in regard to having Alzheimer’s. Also, this 
study is the first ecological study using secondary data 
that both of the researchers had completed. So, we recog-
nize that there may be limitations with regards to our prior 
knowledge and experience. 
Some strengths in this study are that the collection 
and interpretation of data help to fill in gaps in the liter-
ature published in regard to research conducted to ana-
lyze minority populations such as Hispanics and African 
American communities. Filling in this gap in current 
literature will promote future research on this topic to 
identify which factors are impacting minority populations 
the most. Which can possibly result in the identification 
of key components that lead to increased rates of Alzhei-
mer’s mortality. It will shed light on the importance of 
minority populations and their health in relation to Alzhei-
mer’s disease which evidence clearly shows that dispari-
ties exist. Furthermore, the probability of having a stroke 
and disparities regarding education, income, and access to 
health care/insurance that minorities experience can im-
pact Alzheimer's onset.
6. Conclusions
Our results showed that being a part of the Hispanic 
population, being over 65 years old, history of stroke, and 
income are significantly associated with mortality due 
to Alzheimer’s disease. We rejected our null hypothesis, 
which was that being a part of a minority group in the 
United States is not associated with increased risk for dy-
ing of Alzheimer’s. 
We hope that our study promotes minority research 
and recognizing gaps in healthcare by majority and mi-
nority. In addition, by pointing out disparities in access 
to healthcare and identifying at risk communities who 
suffer the most because of Alzheimer's, a comprehensive 
intervention strategy can be developed to promote change 
and advocate for more resources. We can infer that mi-
nority populations are much more likely to experience 
social determinants of health that negatively impact health 
outcomes, and thereby increase risk of dying from Alzhei-
mer’s disease. 
Our findings explain how an association exists between 
Alzheimer’s mortality rates with being a part of a minori-
ty population in the United States. Furthermore, the study 
found that mortality due to Alzheimer’s is indeed increas-
ing in the United States, and death results from years of 
living with progressive negative health conditions. We 
found that specific factors such as access to healthcare 
could possibly impact Alzheimer’s mortality in the United 
States and minority populations face disparities in com-
parison to other populations.
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